A meta-analysis found that PR-positive breast cancers have a lower risk of bone metastasis, while HER2-positive, lymph node metastasis-positive, nonlobular, or ductal breast cancers and increasing tumor stage have a higher risk of bone metastasis [25]. This evidence concerns the gene ERBB2 and bone metastasis.